Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3-Reference-Cited by-同舟云学术

Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3

Published:1995-11-03 Issue:5237 Volume:270 Page:794-797
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Thomis Daniel C.¹,Gurniak Christine B.¹,Tivol Elizabeth²,Sharpe Arlene H.²,Berg Leslie J.¹

Affiliation:

1. D. C. Thomis, C. B. Gurniak, L. J. Berg, Department of Molecular and Cellular Biology, Harvard University, 16 Divinity Avenue, Cambridge, MA 02138, USA.

2. E. Tivol and A. H. Sharpe, Departments of Pathology, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference25 articles.

1. CYCLOSPORINE-A, FK506, AND RAPAMYCIN - BINDING TO IMMUNOPHILINS AND BIOLOGICAL ACTION;BIERER B.E.;LYMPHOCYTE ACTIVATION,1994

2. Prevention of T Cell Anergy by Signaling Through the γ c Chain of the IL-2 Receptor

3. DEFECTIVE LYMPHOID DEVELOPMENT IN MICE LACKING EXPRESSION OF THE COMMON CYTOKINE RECEPTOR-GAMMA CHAIN;CAO X.Q.;IMMUNITY,1995

4. LYMPHOID DEVELOPMENT IN MICE WITH A TARGETED DELETION OF THE INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN;DISANTO J.P.;PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,1995

5. IDENTIFICATION AND DISTRIBUTION OF THE COSTIMULATORY RECEPTOR CD28 IN THE MOUSE;GROSS J.A.;JOURNAL OF IMMUNOLOGY,1992

Cited by 500 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic review of janus kinase inhibitors and its clinical implications for the management of rheumatoid arthritis;Expert Opinion on Drug Metabolism & Toxicology;2024-06-26

2. Janus kinase inhibition in the treatment and prevention of graft-versus-host disease;Frontiers in Immunology;2024-02-06

3. Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship;Molecular Diversity;2024-01-18

4. Pathogenetic mechanisms and treatment targets in cerebral malaria;Nature Reviews Neurology;2023-10-19

5. Scope of JAK Inhibitors in Children: Recent Evidence and Way Forward;Pediatric Drugs;2023-09-29